🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The main objective of this trial is to investigate the relative bioavailabi...
Status
Completed
Location
Humanpharmakologisches Zentrum Biberach
Start Date
2019-02-11
Trial ID
NCT03817476
Treatments Being Tested
The present multi-center, open-label, single-arm study aims to evaluate the...
Status
Completed
Location
Novartis Investigative Site
Start Date
2012-06
Trial ID
NCT01626222
Treatments Being Tested
This study is an open-label, randomized, single dose, multi-stage, cross-ov...
Status
Completed
Location
GSK Investigational Site
Start Date
2011-11-06
Trial ID
NCT01495026
Treatments Being Tested
The purpose of this study is to assess and compare the pharmacokinetics (PK...
Status
Completed
Location
Multiple Locations
Start Date
2008-05
Trial ID
NCT01311739
Treatments Being Tested
The main goal of this study is to develop a new oro-dissolvable/dispersible...
Status
Unknown
Location
Mansoura University
Start Date
2020-06-01
Trial ID
NCT04564144
Treatments Being Tested
To evaluate the relative bioavailability of ticagrelor for the different fo...
Status
Completed
Location
Research Site
Start Date
2017-05-12
Trial ID
NCT03126695
The study will evaluate whether the blood concentrations of eletriptan admi...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2009-04
Trial ID
NCT00871806
The purpose of this clinical trial is to compare the blood tafamidis concen...
Status
Active Not Recruiting
Location
P-One Clinic
Start Date
2026-05-11
Trial ID
NCT07587697
The aims of this study are to extensively study the levels of CD25-Receptor...
Status
Completed
Location
Novartis Investigative Site
Start Date
2012-03
Trial ID
NCT01596062
Treatments Being Tested
The purpose of this study is to estimate the relative bioavailability of PF...
Status
Completed
Location
Pfizer Clinical Research Unit - New Haven
Start Date
2022-03-10
Trial ID
NCT05263921
Treatments Being Tested